Compare TCPC & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCPC | SLP |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | 213 |
| Industry | Finance/Investors Services | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.8M | 367.9M |
| IPO Year | 2006 | 1996 |
| Metric | TCPC | SLP |
|---|---|---|
| Price | $3.23 | $18.17 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $3.50 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 919.1K | 481.3K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | ★ 18.23% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $69.77 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $3.08 | $11.09 |
| 52 Week High | $7.92 | $21.01 |
| Indicator | TCPC | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 30.66 | 67.04 |
| Support Level | N/A | $17.74 |
| Resistance Level | $3.75 | $18.76 |
| Average True Range (ATR) | 0.12 | 0.39 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 20.27 | 87.35 |
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve its investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights, or direct equity investments.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.